A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 39/00 (2006.01) A61P 17/00 (2006.01) A61P 31/00 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) C07K 14/71 (2006.01)
Patent
CA 2146973
A method of treating TGF-.beta. excess is disclosed. The treatment is parenteral, oral or topical administration of TGF-.beta. re-ceptor fragment. Particularly effective is a soluble receptor fragment which resembles the extracellular portion of TGF-.beta. binding protein II.
Carrillo Pedro A.
Dasch James R.
Olsen David R.
Segarini Patricia R.
Celtrix Pharmaceuticals Inc.
Fetherstonhaugh & Co.
LandOfFree
Uses of tgf-.beta. receptor fragment as a therapeutic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of tgf-.beta. receptor fragment as a therapeutic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of tgf-.beta. receptor fragment as a therapeutic agent will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1860895